SAN DIEGO--(BUSINESS WIRE)--Dec. 16, 2005--PURE Bioscience (OTCBB:PURE) today reported financial results for the quarter ended October 31, 2005. Revenues for the fiscal quarter were $55,200 compared with revenues of $25,500 from comparable continuing operations in the same quarter last year. The Company reported a loss of $(609,500), or $(0.04) per share, for the current quarter, compared with a loss of $(632,900), or $(0.04) per share, from continuing operations in the prior quarter.
